Literature DB >> 27174676

Control of neuronal synapse specification by a highly dedicated alternative splicing program.

Lisa Traunmüller1, Andrea M Gomez1, Thi-Minh Nguyen1, Peter Scheiffele2.   

Abstract

Alternative RNA splicing represents a central mechanism for expanding the coding power of genomes. Individual RNA-binding proteins can control alternative splicing choices in hundreds of RNA transcripts, thereby tuning amounts and functions of large numbers of cellular proteins. We found that the RNA-binding protein SLM2 is essential for functional specification of glutamatergic synapses in the mouse hippocampus. Genome-wide mapping revealed a markedly selective SLM2-dependent splicing program primarily consisting of only a few target messenger RNAs that encode synaptic proteins. Genetic correction of a single SLM2-dependent target exon in the synaptic recognition molecule neurexin-1 was sufficient to rescue synaptic plasticity and behavioral defects in Slm2 knockout mice. These findings uncover a highly selective alternative splicing program that specifies synaptic properties in the central nervous system.
Copyright © 2016, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27174676     DOI: 10.1126/science.aaf2397

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  50 in total

1.  Postsynaptic δ1 glutamate receptor assembles and maintains hippocampal synapses via Cbln2 and neurexin.

Authors:  Wucheng Tao; Javier Díaz-Alonso; Nengyin Sheng; Roger A Nicoll
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-21       Impact factor: 11.205

2.  LARGE, an intellectual disability-associated protein, regulates AMPA-type glutamate receptor trafficking and memory.

Authors:  Bo Am Seo; Taesup Cho; Daniel Z Lee; Joong-Jae Lee; Boyoung Lee; Seong-Wook Kim; Hee-Sup Shin; Myoung-Goo Kang
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-18       Impact factor: 11.205

Review 3.  The role of RNA alternative splicing in regulating cancer metabolism.

Authors:  Itamar Kozlovski; Zahava Siegfried; Adi Amar-Schwartz; Rotem Karni
Journal:  Hum Genet       Date:  2017-04-20       Impact factor: 4.132

4.  A Sam68-dependent alternative splicing program shapes postsynaptic protein complexes.

Authors:  Harald Witte; Dietmar Schreiner; Peter Scheiffele
Journal:  Eur J Neurosci       Date:  2019-01-29       Impact factor: 3.386

Review 5.  Alternative splicing as a regulator of development and tissue identity.

Authors:  Francisco E Baralle; Jimena Giudice
Journal:  Nat Rev Mol Cell Biol       Date:  2017-05-10       Impact factor: 94.444

6.  Mechanisms of Neuronal Alternative Splicing and Strategies for Therapeutic Interventions.

Authors:  Eduardo Javier Lopez Soto; Michael J Gandal; Thomas Gonatopoulos-Pournatzis; Elizabeth A Heller; Diou Luo; Sika Zheng
Journal:  J Neurosci       Date:  2019-10-16       Impact factor: 6.167

7.  Subcellular Compartmentation of Alternatively Spliced Transcripts Defines SERINE/ARGININE-RICH PROTEIN30 Expression.

Authors:  Lisa Hartmann; Theresa Wießner; Andreas Wachter
Journal:  Plant Physiol       Date:  2018-03-01       Impact factor: 8.340

8.  A Statistical Framework for Mapping Risk Genes from De Novo Mutations in Whole-Genome-Sequencing Studies.

Authors:  Yuwen Liu; Yanyu Liang; A Ercument Cicek; Zhongshan Li; Jinchen Li; Rebecca A Muhle; Martina Krenzer; Yue Mei; Yan Wang; Nicholas Knoblauch; Jean Morrison; Siming Zhao; Yi Jiang; Evan Geller; Iuliana Ionita-Laza; Jinyu Wu; Kun Xia; James P Noonan; Zhong Sheng Sun; Xin He
Journal:  Am J Hum Genet       Date:  2018-05-10       Impact factor: 11.025

Review 9.  Alternative splicing of neuronal genes: new mechanisms and new therapies.

Authors:  Diane Lipscombe; Eduardo Javier Lopez Soto
Journal:  Curr Opin Neurobiol       Date:  2019-01-28       Impact factor: 6.627

Review 10.  Trafficking in Alzheimer's Disease: Modulation of APP Transport and Processing by the Transmembrane Proteins LRP1, SorLA, SorCS1c, Sortilin, and Calsyntenin.

Authors:  Simone Eggert; Carolin Thomas; Stefan Kins; Guido Hermey
Journal:  Mol Neurobiol       Date:  2017-10-27       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.